13F

Stock

Kiora Pharmaceuticals Inc

Ticker not mapped · held by 17 managers

Reported value

$654.6K

Holders

17

+4 new · −8 exited

Holders’ est. mark

−$9.06K

Price effect on 10 books still in the name

Largest holder

$324.1K

ADAR1 Capital Management, LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
ADAR1 Capital Management, LLC167.9K$324.1K−$6.72KCut−$6.72K
Citadel49.5K$95.6K−$896Added$51.5K
GEODE CAPITAL MANAGEMENT, LLC47.9K$92.3K−$880Added$49K
VANGUARD CAPITAL MANAGEMENT LLC19.9K$38.3KHeld
XTX Topco Ltd14.7K$28.4K−$479Added$4.83K
VANGUARD FIDUCIARY TRUST CO13K$25.1KHeld
TWO SIGMA SECURITIES, LLC12K$23.2KNew
Rangeley Capital, LLC10K$19.3KNew
MORGAN STANLEY1.41K$2.72KNew
UBS Group AG1.3K$2.51K−$37Added$714
Tower Research Capital LLC (TRC)995$1.92K−$40Cut−$1.2K
SBI Securities Co., Ltd.256$494−$10Cut−$10
Vanguard Global Advisers, LLC200$386Held
BlackRock, Inc.58$112−$2Cut−$2
Caitong International Asset Management Co., Ltd6$12New
Activest Wealth Management2$4$0Held
OSAIC HOLDINGS, INC.2$3$0Held

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.